The heterogenic background of breast cancer such as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2), didn't seem to complicate the metabolite profile of breast cancer. This evidence concerns the gene ESR1 and breast cancer.